MIDAS Strategy: Minimizing Implantat Depth According to Membranous Septum

Permanent pacemaker implantation following transcatheter aortic valve replacement (TAVR) continues to be one of the most frequent complications. Even though its real impact on prognosis continues to be controversial, its impact on healthcare cost is out of the question, in addition to being uncomfortable for patients. 

¿Fin de la discusión sobre el impacto del marcapaso post TAVI?

This study, soon to be published in J Am Coll Cardiol Intv, sought a way to minimize the risk of pacemaker implantation post TAVR with contemporary repositionable self-expanding transcatheter aortic valve replacement (TAVR).

It included 248 consecutive severe aortic stenosis patients undergoing self-expanding TAVR under conscious sedation with standard approach. Researchers looked at multiple factors that might contribute to definite pacemaker implantation rate and created an anatomically guided minimizing depth according to membranous septum (MIDAS). The idea behind this technique is to minimize implant depth relative to non-coronary sinus/ membranous septum distance. 


Read also: The Era of Provisional Stenting for Bifurcations Comes to an End.


Pacemaker implantation predictors post TAVR were prior right bundle branch block, membranous septum length, larger devices (Evolut 34 XL) and deeper implantation relative to non-coronary cusp /membranous septum distance.

At multivariable analyzis, the only independent predictors were deeper implantation than the distance to membranous sinus (OR: 8.04 CI 95%: 2.58 to 25.04]; p<0.001) and Evolut 34 XL prosthesis (OR: 4.96 CI 95%: 1.68 to 14.63]; p=0.004).

The MIDAS technique was done prospectively in 100 consecutive patients after this analyzis. Operators’ goal was pre-release depth in relation to the noncoronary cusp of less than the length of the membranous septum.

With this technique, researchers succeeded in reducing pacemaker implantation rate from 9.7% to 3% (p=0.035) and left bundle branch block from 25.8% to 9% (p<0.001).

Conclusion

Using the MIDAS technique, we can find the right implantation depth specific to each patient, which predicts and reduces definite pacemaker implantation rate post self-expandable contemporary valve implantation. 

Original Title: Minimizing Permanent Pacemaker Following Repositionable Self-Expanding Transcatheter Aortic Valve Replacement.

Reference: Hasan Jilaihawi et al. J Am Coll Cardiol Intv 2019, online before print.



Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Prospective Analysis of the Feasibility of the PASCAL System for Transcatheter Mitral Repair: OneForAll Registry

Courtesy of Dr. Juan Manuel Pérez. Mitral transcatheter edge-to-edge repair (M-TEER) is an effective option for patients with severe mitral regurgitation who are at high...

Left Bundle Branch Block after TAVR: What Is Its Impact?

Courtesy of Dr. Juan Manuel Pérez. Left bundle branch block (LBBB) is a common complication following transcatheter aortic valve replacement (TAVR), which can be either...

Multicenter Experience with 3D Intracardiac Echocardiography for Guiding Interventional Cardiac Procedures

Courtesy of Dr. Juan Manuel Pérez. Imaging techniques play a fundamental role in interventional cardiac procedures. Intracardiac echocardiography (ICE) appears as an alternative to transesophageal...

Pathology of Self-Expanding Transcatheter Aortic Bioprostheses and Hypoattenuated Leaflet Thickening

Courtesy of Dr. Juan Manuel Pérez. Despite the available long term followup data on of transcatheter aortic valve replacement (TAVR), bioprosthesis durability continues under debate....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

STRIDE: Semaglutide in Patients with Peripheral Arterial Disease and Type II Diabetes

Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries. This condition...